PDCD1 and neoplasm: When performing anti-PD-1 treatment alongside ACT of sgElovl1 pmel-1 T cells, we observed a delay in tumour growth (Fig. 3k and Extended Data Fig. 3f,g), reflected by a lower tumour weight (Fig. 3l), compared with sgNT pmel-1 T cell administration.